Should lactate be added to Tokyo criteria for the evaluation of patients with acute cholangitis?
- PMID: 35133602
- DOI: 10.1007/s11845-022-02941-y
Should lactate be added to Tokyo criteria for the evaluation of patients with acute cholangitis?
Abstract
Background: Tokyo guidelines (TG13/18) are used for the severity assessment of acute cholangitis (AC). Lactate is a clinical marker of tissue hypoxia and disease severity, independent from blood pressure.
Aim: The aim of this study is to investigate the relationship between blood lactate level and TG13/18 criteria in patients diagnosed with AC.
Methods: One hundred fifteen patients with AC were included in this retrospective study. Demographic characteristics of the patients and laboratory data were scanned from their hospital medical records. According to TG13/18 guidelines, the patients were divided into 3 groups as mild (grade 1), moderate (grade 2), and severe (grade 3) AC.
Results: Sixty three (54.7%) of the patients were grade 1, 37 (32.1%) were grade 2, and 15 (13.0%) were grade 3. It was found that blood lactate level increased significantly from grade 1 to grade 3 (p < 0.001). In logistic regression analysis, white blood cell (WBC) count, total bilirubin and blood lactate levels independently determined the patients to be grade 2 or 3 AC. When the blood lactate cut-off value was taken as 16.5 mg/dL, we diagnosed grade 2 or 3 AC with a sensitivity of 78.8% and a specificity of 75.7%. From among lactate, WBC, and C reactive protein, lactate showed the highest value regarding the area under the curve, which is an index for predicting grade III upon ROC analysis.
Conclusion: The blood lactate level is associated with the severity of AC. In addition to TG13/18 guidelines, blood lactate level can be a useful biomarker in the severity grading of AC.
Keywords: Acute cholangitis; Lactate; Tokyo guidelines.
© 2022. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.
References
-
- Tan M, Jensen TG, Nielsen SL et al (2021) Analysis of patterns of bacteremia and 30-day mortality in patients with acute cholangitis over a 25-year period. Scand J Gastroenterol 56(5):578–584. https://doi.org/10.1080/00365521.2021.1902558 . Epub 2021 Mar 25 - DOI - PubMed
-
- Shenoy SM, Shenoy S, Gopal, S et al (2014) Clinicomicrobiological analysis of patients with cholangitis. Indian J Med Microbiol 32(2):157–60. https://doi.org/10.4103/0255-0857.129802
-
- Park JW, Lee JK, Lee KT et al (2014) How to interpret the bile culture results of patients with biliary tract infections. Clin Res Hepatol Gastroenterol 38:300–309 - DOI
-
- Kiriyama S, Takada T, Strasberg SM et al (2013) Tokyo Guidelines Revision Committee. TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos) J Hepatobiliary Pancreat Sci 20:24–34. https://doi.org/10.1007/s00534-012-0561-3
-
- Kiriyama S, Kozaka K, Takada T et al (2018) Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos) J Hepatobiliary Pancreat Sci 25:17–30. https://doi.org/10.1002/jhbp.512 . Epub 2018 Jan 5
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials